News & Stories

MSF condemns outrageous attack in UN protection site, calls for protection of civilians and continued scale-up of humanitarian response in Malakal

March 2, 2016

(March 2 – Juba, South Sudan) The attack in the Malakal protection of civilians site (PoC) on February 17th and 18th is another horrifying instance of brutality in a two year conflict marked by utter

View

Hearing on Gilead's patent for hepatitis C drug, sofosbuvir, begins at patent office

February 29, 2016

View

Hearing on Gilead's patent for hepatitis C drug, sofosbuvir, begins at patent office

February 26, 2016

View

Doctors Without Borders blasts $1700 price tag of Otsuka TB drug

February 26, 2016

View

Activists raise concern over new life-saving TB drug cost

February 26, 2016

View

MSF expresses concern over high price of new TB drug, delamanid of Otsuka Pharma

February 26, 2016

View

"Doctors Without Borders blasts $1700 price tag of Otsuka TB drug"

February 26, 2016

View

Patent challenge hearing on Gilead hepatitis C drug sofosbuvir starts in India

February 26, 2016

‘Patent opposition’ seeks to ensure millions of people left out of Gilead licensing deals can access affordable generics New Delhi/New York, 26 February 2016— In proceedings that could have major implications for millions of people

View

Developing Countries Hit with High Price Tag for Critical New TB Drug

February 25, 2016

View

Patient groups raise concern over affordability of new TB drug

February 25, 2016

View

Another breath of life

February 24, 2016

Name : Designation : Although he is wearing a mask, you can see the hopeful smile in Danish’s eyes when he enters the Doctors Without Borders / Médecins Sans Frontières (MSF) clinic in Mumbai,

View